Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension)
Clinical trial NCT00642889 · COMPLETED
Trial details
- NCT number
- NCT00642889
- Sponsor
- Newron Pharmaceuticals SPA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2007-01-01
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.